| 1 |
29845287 | Antitumor effect of lapatinib and cytotoxic agents by suppression of E2F1 in HER2‑positive breast cancer. | 2018 Jul |
2 |
| 2 |
25700774 | Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker. | 2015 Sep |
1 |
| 3 |
21623901 | Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants. | 2012 Aug |
3 |
| 4 |
20424000 | Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification. | 2010 May |
1 |
| 5 |
19529774 | Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2. | 2009 Jun 16 |
5 |